In the previously mentioned study investigating altered RecQ expression and prognostic value, overexpression of BLM, RECQL1, and RECQL5 in AML patients with normal karyotype were associated with poor prognosis (Viziteu et al., 2016). The gene discussed is BLM; the disease is acute myeloid leukemia.